Interpace Biosciences Investor Relations Material
Latest events
Q1 2025
8 May, 2025
Q4 2024
30 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Interpace Biosciences Inc
Access all reports
Interpace Biosciences, Inc. is a U.S.-based company specializing in molecular diagnostic tests and pathology services. The company provides diagnostic solutions for detecting, monitoring, and managing risks related to cancer, particularly in areas such as thyroid, gastrointestinal, and lung cancers. Interpace Biosciences serves healthcare providers, patients, and pharmaceutical companies by offering personalized diagnostic information to guide clinical decision-making. The company is headquartered in Parsippany, New Jersey, and its shares are listed on the OTCQB.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
IDXG
Country
🇺🇸 United States